↓ Skip to main content

Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer

Overview of attention for article published in BMC Clinical Pharmacology, February 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

blogs
1 blog
patent
1 patent

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer
Published in
BMC Clinical Pharmacology, February 2011
DOI 10.1186/1472-6904-11-1
Pubmed ID
Authors

Jan B Howes, Paul L de Souza, Leanne West, Li Jiu Huang, Laurence G Howes

Abstract

Phenoxodiol is a novel isoflavone currently being studied in clinical trials for the treatment of cancer. This study reports the pharmacokinetics of phenoxodiol in patients with cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 22%
Student > Bachelor 6 22%
Professor 2 7%
Librarian 2 7%
Student > Ph. D. Student 2 7%
Other 4 15%
Unknown 5 19%
Readers by discipline Count As %
Medicine and Dentistry 10 37%
Biochemistry, Genetics and Molecular Biology 2 7%
Chemistry 2 7%
Computer Science 2 7%
Nursing and Health Professions 1 4%
Other 3 11%
Unknown 7 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2022.
All research outputs
#2,756,409
of 22,908,162 outputs
Outputs from BMC Clinical Pharmacology
#13
of 56 outputs
Outputs of similar age
#17,347
of 183,234 outputs
Outputs of similar age from BMC Clinical Pharmacology
#1
of 3 outputs
Altmetric has tracked 22,908,162 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 56 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.1. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,234 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them